Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Targeting PTEN in Colorectal Cancers.

Kotelevets L, Scott MGH, Chastre E.

Adv Exp Med Biol. 2018;1110:55-73. doi: 10.1007/978-3-030-02771-1_5. Review.

PMID:
30623366
2.

Interest of cytology combined with Xpert® HPV and Anyplex® II HPV28 Detection human papillomavirus (HPV) typing: differential profiles of anal and cervical HPV lesions in HIV-infected patients on antiretroviral therapy.

Nassereddine H, Charpentier C, Bucau M, Joly V, Bienvenu L, Davitian C, Abramowitz L, Benabderrahmane D, Kotelevets L, Chastre E, Lehy T, Walker F.

HIV Med. 2018 Nov;19(10):698-707. doi: 10.1111/hiv.12661. Epub 2018 Jul 30.

PMID:
30062761
3.

The Rac1 splice form Rac1b favors mouse colonic mucosa regeneration and contributes to intestinal cancer progression.

Kotelevets L, Walker F, Mamadou G, Lehy T, Jordan P, Chastre E.

Oncogene. 2018 Nov;37(46):6054-6068. doi: 10.1038/s41388-018-0389-7. Epub 2018 Jul 9.

PMID:
29985482
4.

A Squalene-Based Nanomedicine for Oral Treatment of Colon Cancer.

Kotelevets L, Chastre E, Caron J, Mougin J, Bastian G, Pineau A, Walker F, Lehy T, Desmaële D, Couvreur P.

Cancer Res. 2017 Jun 1;77(11):2964-2975. doi: 10.1158/0008-5472.CAN-16-1741. Epub 2017 Apr 17. Erratum in: Cancer Res. 2017 Nov 1;77(21):6048.

5.

Decreased vasorelaxation induced by iloprost during acute inflammation in human internal mammary artery.

Foudi N, Ozen G, Amgoud Y, Louedec L, Choqueux C, Badi A, Kotelevets L, Chastre E, Longrois D, Norel X.

Eur J Pharmacol. 2017 Jun 5;804:31-37. doi: 10.1016/j.ejphar.2017.03.060. Epub 2017 Mar 31.

PMID:
28373136
6.

Nanotechnologies for the treatment of colon cancer: From old drugs to new hope.

Kotelevets L, Chastre E, Desmaële D, Couvreur P.

Int J Pharm. 2016 Nov 30;514(1):24-40. doi: 10.1016/j.ijpharm.2016.06.005. Review.

PMID:
27863668
7.

Evidence for different expression profiles for c-Met, EGFR, PTEN and the mTOR pathway in low and high grade endometrial carcinomas in a cohort of consecutive women. Occurrence of PIK3CA and K-Ras mutations and microsatellite instability.

Thoury A, Descatoire V, Kotelevets L, Kannengiesser C, Bertrand G, Theou-Anton N, Frey C, Genestie C, Raymond E, Chastre E, Lehy T, Walker F.

Histol Histopathol. 2014 Nov;29(11):1455-66. doi: 10.14670/HH-29.1455. Epub 2014 May 8.

PMID:
24811063
8.

Ibuprofen inhibits colitis-induced overexpression of tumor-related Rac1b.

Matos P, Kotelevets L, Goncalves V, Henriques AF, Henriques A, Zerbib P, Moyer MP, Chastre E, Jordan P.

Neoplasia. 2013 Jan;15(1):102-11. Erratum in: Neoplasia. 2015 Sep;17(9):755. Henriques, Andreia [Corrected to Henriques, Andreia F. A.].

9.

Prostaglandin E₂ induced contraction of human intercostal arteries is mediated by the EP₃ receptor.

Longrois D, Gomez I, Foudi N, Topal G, Dhaouadi M, Kotelevets L, Chastre E, Norel X.

Eur J Pharmacol. 2012 Apr 15;681(1-3):55-9. doi: 10.1016/j.ejphar.2012.01.041. Epub 2012 Feb 12.

PMID:
22342278
10.

Distinct functional outputs of PTEN signalling are controlled by dynamic association with β-arrestins.

Lima-Fernandes E, Enslen H, Camand E, Kotelevets L, Boularan C, Achour L, Benmerah A, Gibson LC, Baillie GS, Pitcher JA, Chastre E, Etienne-Manneville S, Marullo S, Scott MG.

EMBO J. 2011 Jun 3;30(13):2557-68. doi: 10.1038/emboj.2011.178.

11.

Identification of mitogen-activated protein/extracellular signal-responsive kinase kinase 2 as a novel partner of the scaffolding protein human homolog of disc-large.

Maïga O, Philippe M, Kotelevets L, Chastre E, Benadda S, Pidard D, Vranckx R, Walch L.

FEBS J. 2011 Aug;278(15):2655-65. doi: 10.1111/j.1742-4658.2011.08192.x. Epub 2011 Jun 13.

12.

Differential reactivity of human mammary artery and saphenous vein to prostaglandin E(2) : implication for cardiovascular grafts.

Foudi N, Kotelevets L, Gomez I, Louedec L, Longrois D, Chastre E, Norel X.

Br J Pharmacol. 2011 Jun;163(4):826-34. doi: 10.1111/j.1476-5381.2011.01264.x.

13.

TRIP6, a novel molecular partner of the MAGI-1 scaffolding molecule, promotes invasiveness.

Chastre E, Abdessamad M, Kruglov A, Bruyneel E, Bracke M, Di Gioia Y, Beckerle MC, van Roy F, Kotelevets L.

FASEB J. 2009 Mar;23(3):916-28. doi: 10.1096/fj.08-106344. Epub 2008 Nov 18.

PMID:
19017743
14.

Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype.

Foudi N, Kotelevets L, Louedec L, Leséche G, Henin D, Chastre E, Norel X.

Br J Pharmacol. 2008 Aug;154(8):1631-9. doi: 10.1038/bjp.2008.214. Epub 2008 Jun 2.

15.

Resistin-like molecule beta regulates intestinal mucous secretion and curtails TNBS-induced colitis in mice.

Krimi RB, Kotelevets L, Dubuquoy L, Plaisancié P, Walker F, Lehy T, Desreumaux P, Van Seuningen I, Chastre E, Forgue-Lafitte ME, Marie JC.

Inflamm Bowel Dis. 2008 Jul;14(7):931-41. doi: 10.1002/ibd.20420.

PMID:
18300276
16.

Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis.

Szado T, Vanderheyden V, Parys JB, De Smedt H, Rietdorf K, Kotelevets L, Chastre E, Khan F, Landegren U, Söderberg O, Bootman MD, Roderick HL.

Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2427-32. doi: 10.1073/pnas.0711324105. Epub 2008 Feb 4.

17.

A new mRNA splice variant coding for the human EP3-I receptor isoform.

Kotelevets L, Foudi N, Louedec L, Couvelard A, Chastre E, Norel X.

Prostaglandins Leukot Essent Fatty Acids. 2007 Oct-Nov;77(3-4):195-201. Epub 2007 Nov 19.

PMID:
18023986
18.

Protein kinase WNK2 inhibits cell proliferation by negatively modulating the activation of MEK1/ERK1/2.

Moniz S, Veríssimo F, Matos P, Brazão R, Silva E, Kotelevets L, Chastre E, Gespach C, Jordan P.

Oncogene. 2007 Sep 6;26(41):6071-81. Epub 2007 Jul 30. Erratum in: Oncogene. 2008 Jan 3;27(1):155. Kotevelets, L [corrected to Kotelevets, L].

PMID:
17667937
19.

Dihydroxyphenylethanol induces apoptosis by activating serine/threonine protein phosphatase PP2A and promotes the endoplasmic reticulum stress response in human colon carcinoma cells.

Guichard C, Pedruzzi E, Fay M, Marie JC, Braut-Boucher F, Daniel F, Grodet A, Gougerot-Pocidalo MA, Chastre E, Kotelevets L, Lizard G, Vandewalle A, Driss F, Ogier-Denis E.

Carcinogenesis. 2006 Sep;27(9):1812-27. Epub 2006 Mar 7.

PMID:
16524888
20.
21.

Cholinesterase activity in human pulmonary arteries and veins: correlation with mRNA levels.

Kotelevets L, Walch L, Chastre E, Chatonnet A, Dulmet E, Brink C, Norel X.

Life Sci. 2005 Mar 25;76(19):2211-20. Epub 2005 Jan 27.

PMID:
15733936
22.

Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness.

Kotelevets L, van Hengel J, Bruyneel E, Mareel M, van Roy F, Chastre E.

FASEB J. 2005 Jan;19(1):115-7. Epub 2004 Nov 1.

PMID:
15629897
23.

The lipid phosphatase activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness.

Kotelevets L, van Hengel J, Bruyneel E, Mareel M, van Roy F, Chastre E.

J Cell Biol. 2001 Dec 24;155(7):1129-35. Epub 2001 Dec 24.

24.

Phenotypic and functional characterization of human thymic stromal cell lines.

Wakkach A, Chastre E, Bruand C, Cohen-Kaminsky S, Emami S, Gespach C, Berrih-Aknin S.

Cell Mol Biol (Noisy-le-grand). 2001 Feb;47(1):167-78.

PMID:
11292252
25.

Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways.

Attoub S, Noe V, Pirola L, Bruyneel E, Chastre E, Mareel M, Wymann MP, Gespach C.

FASEB J. 2000 Nov;14(14):2329-38.

PMID:
11053255
26.

Deregulated expression of homeobox-containing genes, HOXB6, B8, C8, C9, and Cdx-1, in human colon cancer cell lines.

Vider BZ, Zimber A, Chastre E, Gespach C, Halperin M, Mashiah P, Yaniv A, Gazit A.

Biochem Biophys Res Commun. 2000 Jun 7;272(2):513-8.

PMID:
10833444
27.

B-ind1, a novel mediator of Rac1 signaling cloned from sodium butyrate-treated fibroblasts.

Courilleau D, Chastre E, Sabbah M, Redeuilh G, Atfi A, Mester J.

J Biol Chem. 2000 Jun 9;275(23):17344-8.

28.

Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa.

André T, Kotelevets L, Vaillant JC, Coudray AM, Weber L, Prévot S, Parc R, Gespach C, Chastre E.

Int J Cancer. 2000 Apr 15;86(2):174-81.

29.

Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors.

Jordan P, Brazåo R, Boavida MG, Gespach C, Chastre E.

Oncogene. 1999 Nov 18;18(48):6835-9.

30.

Establishment of a human thymic myoid cell line. Phenotypic and functional characteristics.

Wakkach A, Poea S, Chastre E, Gespach C, Lecerf F, De La Porte S, Tzartos S, Coulombe A, Berrih-Aknin S.

Am J Pathol. 1999 Oct;155(4):1229-40.

31.

Extracellular regulation of cancer invasion: the E-cadherin-catenin and other pathways.

Noë V, Chastre E, Bruyneel E, Gespach C, Mareel M.

Biochem Soc Symp. 1999;65:43-62. Review.

PMID:
10320932
32.
33.

[Tumoral angiogenesis: physiopathology, prognostic value and therapeutic perspectives].

André T, Chastre E, Kotelevets L, Vaillant JC, Louvet C, Balosso J, Le Gall E, Prévot S, Gespach C.

Rev Med Interne. 1998 Dec;19(12):904-13. Review. French.

PMID:
9887458
34.

Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.

Porte H, Triboulet JP, Kotelevets L, Carrat F, Prévot S, Nordlinger B, DiGioia Y, Wurtz A, Comoglio P, Gespach C, Chastre E.

Clin Cancer Res. 1998 Jun;4(6):1375-82.

36.

Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene.

Bara J, Chastre E, Mahiou J, Singh RL, Forgue-Lafitte ME, Hollande E, Godeau F.

Int J Cancer. 1998 Mar 2;75(5):767-73.

37.

Differential expression of the CCK-A and CCK-B/gastrin receptor genes in human cancers of the esophagus, stomach and colon.

Clerc P, Dufresne M, Saillan C, Chastre E, André T, Escrieut C, Kennedy K, Vaysse N, Gespach C, Fourmy D.

Int J Cancer. 1997 Sep 17;72(6):931-6.

38.

Down-regulation of carcinoembryonic antigen family member 2 expression is an early event in colorectal tumorigenesis.

Thompson J, Seitz M, Chastre E, Ditter M, Aldrian C, Gespach C, Zimmermann W.

Cancer Res. 1997 May 1;57(9):1776-84.

39.

Enterocyte differentiation is compatible with SV40 large T expression and loss of p53 function in human colonic Caco-2 cells. Status of the pRb1 and pRb2 tumor suppressor gene products.

Djelloul S, Forgue-Lafitte ME, Hermelin B, Mareel M, Bruyneel E, Baldi A, Giordano A, Chastre E, Gespach C.

FEBS Lett. 1997 Apr 14;406(3):234-42.

40.

Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression.

Vider BZ, Zimber A, Hirsch D, Estlein D, Chastre E, Prevot S, Gespach C, Yaniv A, Gazit A.

Biochem Biophys Res Commun. 1997 Mar 27;232(3):742-8.

PMID:
9126347
41.

[Oncogenic activation of p21ras or pp60c-src in human colonic Caco-2 cells induces post-translation alterations of syndecan-1].

Lévy P, Munier A, Baron-Delage S, Chastre E, Gespach C, Capeau J, Cherqui G.

Bull Cancer. 1997 Mar;84(3):235-7. French.

43.

Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: cooperation between src and HGF/Met in invasion.

Empereur S, Djelloul S, Di Gioia Y, Bruyneel E, Mareel M, Van Hengel J, Van Roy F, Comoglio P, Courtneidge S, Paraskeva C, Chastre E, Gespach C.

Br J Cancer. 1997;75(2):241-50.

44.

Effect of PACAP, VIP, glucagon, and GLP1 on cAMP production and insulin release of HIT-T15 cells is passage dependent.

Boissard C, Marie JC, Phan HH, Chastre E, Rosselin G.

Ann N Y Acad Sci. 1996 Dec 26;805:634-9. No abstract available.

PMID:
8993453
45.

Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone.

Roux S, Quinn J, Pichaud F, Orcel P, Chastre E, Jullienne A, De Vernejoul MC.

J Cell Physiol. 1996 Sep;168(3):489-98.

PMID:
8816903
46.

Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.

Buscail L, Saint-Laurent N, Chastre E, Vaillant JC, Gespach C, Capella G, Kalthoff H, Lluis F, Vaysse N, Susini C.

Cancer Res. 1996 Apr 15;56(8):1823-7.

47.

Deregulation of hexose transporter expression in Caco-2 cells by ras and polyoma middle T oncogenes.

Baron-Delage S, Mahraoui L, Cadoret A, Veissiere D, Taillemite JL, Chastre E, Gespach C, Zweibaum A, Capeau J, Brot-Laroche E, Cherqui G.

Am J Physiol. 1996 Feb;270(2 Pt 1):G314-23.

PMID:
8779974
48.

Evidence for the involvement of the Wnt 2 gene in human colorectal cancer.

Vider BZ, Zimber A, Chastre E, Prevot S, Gespach C, Estlein D, Wolloch Y, Tronick SR, Gazit A, Yaniv A.

Oncogene. 1996 Jan 4;12(1):153-8.

PMID:
8552386
49.

Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract.

Nagano M, Chastre E, Choquet A, Bara J, Gespach C, Kelly PA.

Am J Physiol. 1995 Mar;268(3 Pt 1):G431-42.

PMID:
7534993
50.

Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes.

Porte H, Chastre E, Prevot S, Nordlinger B, Empereur S, Basset P, Chambon P, Gespach C.

Int J Cancer. 1995 Feb 20;64(1):70-5.

PMID:
7665251

Supplemental Content

Loading ...
Support Center